Lisdexamfetamine Dimesylate Capsule
Mylan Pharmaceuticals Inc., a Viatris Company · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 0378-6857-77
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 800-796-9526
- Availability
- Available
- Update date
- 09/17/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)
- Company name
- Mylan Pharmaceuticals Inc., a Viatris Company
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA202835
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE
- Manufacturer name
- Mylan Pharmaceuticals Inc.
- Product NDC
- 0378-6857, 0378-6854, 0378-6855, 0378-6856, 0378-6858, 0378-6859, 0378-6860
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- 6e77cd71-95ae-4fa8-830b-ab62b714e4b9
- SPL set ID
- efbde0f6-b848-4664-b741-c6c630e66108
- Package NDC
- 0378-6854-77, 0378-6855-77, 0378-6856-77, 0378-6857-77, 0378-6858-77, 0378-6859-77, 0378-6860-77
- UNII
- SJT761GEGS